ch.oddb.org
 
Apotheken | Hôpital | Interactions | LiMA | Médecin | Médicaments | Services | T. de l'Autorisation
Information professionnelle sur Verquvo®:Bayer (Schweiz) AG
Information professionnelle complèteDDDAfficher les changementsimprimé 
Composit.Forme gal.Indic./emploiPosolog./mode d'empl.Contre-Ind.PrécautionsInteract.Grossesse
Apt.conduiteEffets indésir.SurdosagePropriétésPharm.cinét.Donn.précl.RemarquesNum. Swissmedic
PrésentationsTitulaireMise à jour 
C01DX22 - VericiguatATC-DDD Version 2016. Source: WHO
C - Cardiovascular System

This group comprises substances used for the treatment of cardiovascular conditions.
Drugs used for the treatment of hypertension are classified in C02 - Antihypertensives, C03 - Diuretics, C07 - Beta blocking agents, C08 - Calcium channel blockers, and C09 - Agents acting on the renin-angiotensin system. For the classification of combination products of antihypertensives from different ATC groups, the following ranking should be used, from higher to lower precedence: C09, C07, C08, and C03.

C01 - Cardiac Therapy
 
C01D - Vasodilators Used in Cardiac Diseases

This group comprises preparations used in ischemic heart diseases. See also C02 - Antihypertensives, C03 - Diuretics, C04 - Peripheral vasodilators, C07 - Beta blocking agents, C08 - Calcium channel blockers and C09 - Agents acting on the renin-angiotensin system.
Combinations with cardiac glycosides, see C01A.
Combinations with rauwolfia alkaloids, see C02AA.
Combinations with beta blocking agents, see C07.
Combinations with calcium channel blockers, see C08.

C01DX - Other Vasodilators Used in Cardiac Diseases

This group comprises vasodilators used in cardiac diseases, which cannot be classified in the preceding groups.

C01DX22 - Vericiguat
Concentr.Adm.RouteNote
 O 
2025 ©ywesee GmbH
Einstellungen | Aide | FAQ | Identification | Contact | Home